Details for New Drug Application (NDA): 022290
✉ Email this page to a colleague
NDA 022290 describes ADREVIEW, which is a drug marketed by Ge Healthcare and is included in one NDA. It is available from one supplier. Additional details are available on the ADREVIEW profile page.
The generic ingredient in ADREVIEW is iobenguane sulfate i-123. One supplier is listed for this compound. Additional details are available on the iobenguane sulfate i-123 profile page.
The generic ingredient in ADREVIEW is iobenguane sulfate i-123. One supplier is listed for this compound. Additional details are available on the iobenguane sulfate i-123 profile page.
Summary for 022290
| Tradename: | ADREVIEW |
| Applicant: | Ge Healthcare |
| Ingredient: | iobenguane sulfate i-123 |
| Patents: | 0 |
Suppliers and Packaging for NDA: 022290
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ADREVIEW | iobenguane sulfate i-123 | SOLUTION;INTRAVENOUS | 022290 | NDA | Medi-Physics Inc. | 17156-235 | 17156-235-01 | 1 VIAL, GLASS in 1 CONTAINER (17156-235-01) / 5 mL in 1 VIAL, GLASS |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10mCi/5ML (2mCi/ML) | ||||
| Approval Date: | Sep 19, 2008 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
